Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 66, Issue 3, Pages 855-868
Publisher
Wiley
Online
2017-04-25
DOI
10.1002/hep.29237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
- (2015) Melchiorre Cervello et al. Oncotarget
- The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma
- (2014) G Tufo et al. CELL DEATH AND DIFFERENTIATION
- Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
- (2014) Sui Peng et al. HEPATOLOGY
- A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase
- (2014) Su Jong Yu et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Protein disulfide isomerase a multifunctional protein with multiple physiological roles
- (2014) Hyder Ali Khan et al. Frontiers in Chemistry
- Protein disulfide isomerase: a promising target for cancer therapy
- (2013) Shili Xu et al. DRUG DISCOVERY TODAY
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
- (2013) Anne Helene Køstner et al. TheScientificWorldJOURNAL
- The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor
- (2012) Jae-Kyung Won et al. Journal of Molecular Cell Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Role of Pro-oncogenic Protein Disulfide Isomerase (PDI) Family Member Anterior Gradient 2 (AGR2) in the Control of Endoplasmic Reticulum Homeostasis
- (2011) Arisa Higa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Reduction of Complex Signaling Networks to a Representative Kernel
- (2011) J.-R. Kim et al. Science Signaling
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
- (2009) Kuen-Feng Chen et al. JOURNAL OF HEPATOLOGY
- Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress
- (2008) P. E. Lovat et al. CANCER RESEARCH
- One step at a time: endoplasmic reticulum-associated degradation
- (2008) Shruthi S. Vembar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search